| Business Summary | | PharmaKinetics
Laboratories,
Inc.
is
a
contract
research
organization
(CRO)
providing
a
range
of
clinical
research
and
development
services
to
the
worldwide
pharmaceutical
industry
and
to
the
biotechnology
industry
in
the
development
of
prescription
and
non-prescription
drug
products.
The
Company
also
provides
bioanalytical
laboratory
services
and
management
and
monitoring
of
clinical
trials
conducted
at
remote
sites,
including
ancillary
services
such
as
protocol
and
case
report
form
design,
data
management
and
biostatistics,
and
regulatory
consulting. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PKLB
is
a
contract
research
organization
providing
a
range
of
clinical
research
and
development
services
to
the
pharmaceutical
and
biotechnology
industries
in
the
development
of
prescription
and
nonprescription
drug
products.
For
the
nine
months
ended
3/31/01,
revenues
rose
14%
to
$6.8
million.
Net
loss
fell
93%
to
$143
thousand.
Revenues
reflect
increased
number
of
contracts
and
Phase
I
services.
Lower
loss
reflects
decreased
S/G/A
and
R&D
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| James Wilkinson, ll, Ph.D., 48 Pres,
CEO, Director | $139K | Taryn Kunkel, 39 CFO,
VP, Treasurer | -- | Cynthia Schurick, 44 VP-Bus.
Devel. | 107K | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|